Discovery of novel selective PI3Kγ inhibitors through combining machine learning-based virtual screening with multiple protein structures and bio-evaluation

Autor: Yanfei Cai, Jingyu Zhu, Yun Chen, Jian Jin, Xinling Zhao, Kan Li, Lei Xu, Huazhong Li, Gang Huang
Rok vydání: 2022
Předmět:
SMILES
simplified molecular input line entry specification

0301 basic medicine
Medicine (General)
Science (General)
CADD
computer-aided drug design

AUC
area under receiver operations characteristic curve

VS
virtual screening

Ionic
ionic interactions

computer.software_genre
PI3Kγ
Machine Learning
Q1-390
Phosphatidylinositol 3-Kinases
0302 clinical medicine
Protein structure
Basic and Biological Science
PI3K
Phosphoinositide 3-kinase

RTK
receptor tyrosine kinases

IMDM
Iscove’s Modified Dulbecco’s Medium

PDB
protein data bank

Cytotoxicity
PARP
poly ADP-ribose polymerase

XP
extra precision

Phosphoinositide-3 Kinase Inhibitors
Selective inhibitor
chemistry.chemical_classification
Multidisciplinary
Chemistry
JN-KI3
GPCR
G protein-coupled receptors

MD
molecular dynamics

Molecular Docking Simulation
PAINS
pan-assay interference compounds

NBC
naive Bayesian classifier

RMSD
root-mean-squared-deviation

RMSF
root-mean-squared-fluctuation

MM/GBSA
molecular mechanics/generalized born surface area

030220 oncology & carcinogenesis
CDRA
confirmatory dose–response assays

SP
standard precision

DMEM
Dulbecco’s Modified Eagle Medium

Virtual screening
Gene isoform
H-bond
hydrogen bond

DS3.5
discovery studio 3.5

Molecular Dynamics Simulation
Machine learning
AKT
protein kinase B

03 medical and health sciences
R5-920
FBS
fetal bovine serum

ROC
receiver operations characteristic

REOS
rapid elimination of swill

Badapple
bioactivity data associative promiscuity pattern learning engine

PAGE
polyacrylamide gel electrophoresis

PI3K/AKT/mTOR pathway
ComputingMethodologies_COMPUTERGRAPHICS
Water Bridge
hydrogen bonds through water molecular bridge

business.industry
Mechanism (biology)
PSA
primary screening assays

030104 developmental biology
Enzyme
Cell culture
Hematologic malignancies
Artificial intelligence
SD
standard deviation

business
ADMET
absorption
distribution
metabolism
excretion
and toxicity

computer
Zdroj: Journal of Advanced Research
Journal of Advanced Research, Vol 36, Iss, Pp 1-13 (2022)
ISSN: 2090-1232
DOI: 10.1016/j.jare.2021.04.007
Popis: Graphical abstract
Highlights • Virtual screening based on machine learning with multiple proteins was developed. • Discovery of a novel PI3Kγ inhibitor integrating virtual screening and bio-assays. • JN-KI3 selective inhibit PI3Kγ enzymatic activity and hematologic malignancies. • The selective γ-inhibition mechanism of JN-KI3 was highlighted using MD simulation.
Introduction Phosphoinositide 3-kinase gamma (PI3Kγ) has been regarded as a promising drug target for the treatment of various diseases, and the diverse physiological roles of class I PI3K isoforms (α, β, δ, and γ) highlight the importance of isoform selectivity in the development of PI3Kγ inhibitors. However, the high structural conservation among the PI3K family makes it a big challenge to develop selective PI3Kγ inhibitors. Objectives A novel machine learning-based virtual screening with multiple PI3Kγ protein structures was developed to discover novel PI3Kγ inhibitors. Methods A large chemical database was screened using the virtual screening model, the top-ranked compounds were then subjected to a series of bio-evaluations, which led to the discovery of JN-KI3. The selective inhibition mechanism of JN-KI3 against PI3Kγ was uncovered by a theoretical study. Results 49 hits were identified through virtual screening, and the cell-free enzymatic studies found that JN-KI3 selectively inhibited PI3Kγ at a concentration as low as 3,873 nM but had no inhibitory effect on Class IA PI3Ks, leading to the selective cytotoxicity on hematologic cancer cells. Meanwhile, JN-KI3 potently blocked the PI3K signaling, finally led to distinct apoptosis of hematologic cell lines at a low concentration. Lastly, the key residues of PI3Kγ and the structural characteristics of JN-KI3, which both would influence γ isoform-selective inhibition, were highlighted by systematic theoretical studies. Conclusion The developed virtual screening model strongly manifests the robustness to find novel PI3Kγ inhibitors. JN-KI3 displays a specific cytotoxicity on hematologic tumor cells, and significantly promotes apoptosis associated with the inhibition of the PI3K signaling, which depicts PI3Kγ as a potential target for the hematologic tumor therapy. The theoretical results reveal that those key residues interacting with JN-KI3 are less common compared to most of the reported PI3Kγ inhibitors, indicating that JN-KI3 has novel structural characteristics as a selective PIK3γ inhibitor.
Databáze: OpenAIRE